Be sure to book your travel arrangements early. We are unable to reserve hotel rooms or airfare for attendees of the symposium. We suggest online travel services such as hotels.com, travelocity.com or orbitz.com. If you would like assistance with hotel arrangements, please contact our Housing Manager, Denise Newman by email: dnew229@aol.com or call 718-835-4911.
Details will follow in due time.
The New York Academy of Medicine
1216 Fifth Avenue (at 103rd Street)
New York, NY 10029, USA
212-822-7200
James G. Krueger, M.D., Ph.D.
Director, Milstein Medical Research Program
Senior Attending Physician
D. Martin Carter Professor in Clinical Investigation
Laboratory of Investigative Dermatology
The Rockefeller University, New York City, USA
Emma Guttman-Yassky, M.D., Ph.D.
Waldman Professor and System Chair
The Kimberly and Eric J. Waldman Department of Dermatology Director,
Center of Excellence in Eczema Director, Laboratory of Inflammatory
Skin Diseases Icahn School of Medicine at Mount Sinai, New York City, USA
Georg Stingl, M.D.
Professor emeritus
Department of Dermatology
Medical University of Vienna, Austria
Patrick M. Brunner, M.D., M.Sc.
Associate Professor
Department of Dermatology
Medical University of Vienna, Austria
Over the last few decades, biomedical research has unraveled a plethora of pathophysiological steps putatively important for human disease development. But it was only in the last few years that a broader translation from basic research efforts to clinical medicine has indeed occurred. This was largely made possible by the close cooperation of basic researchers and clinical investigators, aiming at the development of truly effective therapeutics. Inflammatory skin diseases such as psoriasis and atopic dermatitis serve as an example of this successful bench-to-bedside approach. Currently, more and more therapies are approved as a result of this scientific approach, and many more are on their way.
Nevertheless, a stand-alone meeting in which inflammatory skin diseases and the translational revolution that we are currently experiencing take center stage has been lacking. After three very successful meetings in Vienna in 2014 and 2018 and in New York City in 2016, we have again taken upon the task of organizing such an important meeting in order to continue this path of therapeutic revolution and extend to other inflammatory skin diseases. We want to discuss new concepts and new developments in the field of inflammatory skin diseases and to devise and explore new therapeutic strategies. For the last two meetings, we had been able to attract true leaders in their fields, and we had approximately 600 participants from all over the world at the 2018 meeting in Vienna. We have now established this conference on an every two-year basis, with the next meeting taking place in New York City, USA, November 3-6, 2021.
Angela Christiano (New York, NY, USA): Alopecia areata
Rachael Clark (Boston, MA, USA): Resident memory T cells in human health and disease
Richard Gallo (San Diego, CA, USA): White adipose tissue and its role in innate host defense
Elizabeth Grice (Philadelphia, PA, USA): The skin microbiome in wound healing and regeneration
Christopher Griffiths (Manchester, UK): PSORT – New psoriasis frontiers
Emma Guttman (New York, NY, USA): Atopic dermatitis
Muzlifah Haniffa (Newcastle, UK): Developmental programs in inflammatory skin disease
John Harris (Worcester, MA, USA): Vitiligo
Kenji Kabashima (Kyoto, Japan): Visualization of skin inflammation and resulting immunologic concepts
Daniel Kaplan (Pittsburgh, PA, USA): Immune and neural network interactions
Dan Kastner (Bethesda, MD, USA): Autoinflammatory Diseases
Brian Kim (St Louis, MO, USA): Translating Itch Neuroimmunology to New Therapies
Harald Kittler (Vienna, Austria): Artificial Intelligence in Dermatology
James G. Krueger (New York, NY, USA): The translational revolution in inflammatory skin diseases
Thomas S. Kupper (Boston, MA, USA): Immunity, inflammation and cancer
Mark Lebwohl (New York, NY, USA): Psoriasis – the translational path and access to drugs
Robert Modlin (Los Angeles, CA, USA): Acne
John O’Shea (Bethesda, MD, USA): Janus kinases in inflammation
Amy S. Paller (Chicago, IL, USA): Novel developments in ichthyoses
Virginia Pascual (New York, NY, USA): Lupus
Kristian Reich (Hamburg, Germany): How to successfully perform trials in inflammatory skin diseases
Misha Rosenbach (Philadelphia, PA, USA): Sarcoidosis & Granulomatous diseases
Michael Rosenblum (San Francisco, CA, USA): Regulatory T cells in Skin
Tiffany Scharschmidt (San Francisco, CA, USA): Microbiome and immune interactions early in life
Georg Stingl (Vienna, Austria): Historic perspectives
Victoria P. Werth (Philadelphia, PA, USA): Dermatomyositis
George Yancopoulos* (Tarrytown, NY, USA): New therapeutic frontiers in atopic conditions
Christina Zielinski (Jena, Germany): Regulation of human T-Cell responses by ionic signals in the skin
Wednesday, November 3, 2021
Emma Guttman (New York, NY, USA)
Patrick Brunner (New York, NY, USA)
Joel Gelfand (Philadelphia, PA, USA)
Sonja Ständer (Münster, Germany)
Thursday, November 4, 2021
Brian Brown (New York, NY, USA)
Miriam Merad (New York, NY, USA)
Amos Gilhar (Haifa, Israel)
Emmilia Hodak (Tel Aviv, Israel)
Alice Gottlieb (New York, NY, USA)
Anne Bowcock (New York, NY, USA)
Friday, November 5, 2021
John Carucci (New York, NY, USA)
Leon Kircik (New York, NY, USA)
Robert Bissonnette (Montreal, Canada)
Larisa Geskin (New York, NY, USA)
Sarah Millar (New York, NY, USA)
Ana Pavel (Oxford, MS, USA)
Saturday, November 6, 2021
Natasha Mesinkovska (Irvine, CA)
Brett King (New Haven, CT, USA)
Saakshi Khattri (New York, NY, USA)
Maryanne Makredes Senna (Boston, MA, USA)
*Dr. Yancopoulos is employed by Regeneron Pharmaceuticals. His presentation is not accredited for CME.
Sponsorship & Exhibition
An industry dossier giving detailed information on the possibilities to sponsor various congress items that will greatly promote your company’s image will be available soon. Early reservations ensure availability of prominent items and satellite symposia time slots.
Confirmed Sponsors & Exhibitors
(as of November 2021)
PLATINUM LEVEL SPONSORSHIP
GOLD LEVEL SPONSORSHIP
SILVER LEVEL SPONSORSHIP
BRONZE LEVEL SPONSORSHIP
Congress profile – ISDS 2018
Click HERE for statistical key figures.
Contact
For further information please contact:
Ms. Yvonne Meyers
yvonne.meyers@mountsinai.org